SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is highly trending amid its intensifying bid to acquire Warner Bros. Discovery, recently enhancing its all-cash offer with a significant personal equity financing guarantee to address concerns. This move is sparking widespread community debate over whether Paramount Skydance's revised proposal or Netflix's competing offer provides the superior strategic fit and long-term value for Warner Bros. Discovery shareholders.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is currently trending due to its recent inclusion in the S&P 500, which is driving institutional buying interest alongside robust demand for its memory solutions from AI-driven data centers. The community is actively discussing its remarkable growth fueled by the memory supercycle and BiCS8 technology, while others anticipate potential pullbacks given its significant volatility and rapid appreciation.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is surging following the highly anticipated FDA approval of Yartemlea, its first-in-class therapy for transplant-associated thrombotic microangiopathy (TA-TMA), marking a significant milestone after years of development. The community is actively celebrating this breakthrough, recognizing the drug's potential as the sole approved treatment for a life-threatening condition and discussing its substantial upside given the company's strong financial position and potential for analyst upgrades and future partnerships.

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.

Palatin Technologies Inc.

Palatin Technologies is highly active on the feeds after receiving a NYSE American delisting notice, which the company is appealing while concurrently pursuing new financing. This is juxtaposed against recent positive clinical data in dry eye disease and obesity, including a program showing potential for sustained weight maintenance following GLP-1 therapy cessation. The community remains sharply divided, with bulls highlighting the undervalued pipeline and partnership potential, while bears express deep frustration over management's perceived past financial mismanagement and dilution concerns.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Cola is a trending topic following its strong earnings report, highlighting robust organic revenue and margin growth, coupled with the announcement of a new CEO taking the helm in 2026. The community is intensely discussing its premium valuation compared to peers and widely anticipating potential ventures into cannabis-infused beverages. Persistent talk also surrounds alleged market manipulation impacting its day-to-day price action.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst a polarized debate regarding the impact of new GLP-1 medications and proposed legislation on its core business, while simultaneously expanding its weight-loss program internationally. Despite high institutional ownership and significant short interest fueling talks of a potential squeeze, the community remains divided between those seeing a long-term opportunity and others frustrated by recent stock performance.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is trending amidst significant post-earnings volatility, as its impressive user growth and bookings are being weighed against projections for wider future losses and increased investment in platform safety. The community is deeply divided, with some seeing an attractive dip-buying opportunity given strong engagement, while others express apprehension over persistent unprofitability and a growing number of legal challenges concerning child safety.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is actively discussed following a strategic collaboration with Whitehawk Therapeutics to advance oncology research and recent analyst updates. The community is focused on the company's achievement of positive adjusted EBITDA, debating whether its strong growth in AI-driven precision medicine justifies its current valuation. Many investors are viewing recent price action as a potential buying opportunity within the evolving healthcare AI sector.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF (DIA) is actively discussed as the market grapples with expectations for a year-end "Santa Claus rally" following a robust Q3 GDP report. Investors are weighing DIA's potential stability as a traditional industrial benchmark against broader concerns over market valuations and the ongoing debate surrounding future Fed rate cuts and global liquidity shifts. The community is keenly watching upcoming central bank signals for further market direction.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending due to its AI-powered Athena platform gaining significant traction and recent analyst price target upgrades following the Marigold acquisition. The community largely perceives the stock as deeply undervalued, anticipating a major re-rating driven by robust fundamentals, consistent earnings beats, and upcoming catalysts like its CES 2026 showcase, despite lingering lawsuit concerns from a short-seller report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Total Return Forecasts: Major Asset Classes - Tuesday, Dec. 2  $AGG  $IWV Also $BND https://talkmarkets.com/content/bonds/total-return-forecasts-major-asset-classes-tuesday-dec-2?post=542049&amp;userid=166882

Long-term expectations for the Global Market Index are holding at a 7%-plus annualized total return, based on data through November.